NZM:FRA
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
€59.50
arrow_downward
-0.83%(-0.50) 1D
Sep 4, 8:02:09 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM...
Open
€59.50
High
€59.50
Low
€59.50
Mkt. cap
188.83B
Avg. vol.
1.00
Volume
0.00
52-wk high
€61.00
52-wk low
€44.80
No. of employees
11K
Open
€59.50
High
€59.50
Low
€59.50
Mkt. cap
188.83B
Avg. vol.
1.00
Volume
0.00
52-wk high
€61.00
52-wk low
€44.80
No. of employees
11K
News stories
From web sources and news partners
Prop News Time
·
2 hours ago
Novonesis to invest INR 6,600 crore in Maharashtra’s Patalganga enzyme plant
Milling Middle East & Africa
·
5 hours ago
Novonesis to invest US$704.8M in advanced enzyme production facility in India
Thailand Business News
·
10 hours ago
Novonesis to build next generation enzyme production facility in India
AgroSpectrum India
·
13 hours ago
Novonesis to invest €600 Mn in next-generation enzyme plant in India
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About NOVONESIS NOVOZYMES B Unsponsored Denmark ADR